Jesper Gromada
Private Equity Investor chez Third Rock Ventures LLC
Profil
Jesper brings 25 years of experience in drug development.
Prior to joining Third Rock, Jesper served as Chief Scientific Officer at Exonics Therapeutics (acquired by Vertex Pharmaceuticals) and Laronde Therapeutics.
Previously, Jesper held positions of increasing responsibility at Regeneron, Novartis, Eli Lilly and Novo Nordisk.
Jesper earned his Ph.D.
at the University of Copenhagen, Denmark.
He has contributed to the development of several clinical-stage drug candidates and marketed drugs.
Jesper has published over 200 research papers and patents.
Jesper is interested in combining discoveries in biology and technology for company creation and drug development.
He is impressed with the culture at Third Rock and the approach for build of innovative companies with proven abilities to develop impactful medicines.
Postes actifs de Jesper Gromada
| Sociétés | Poste | Début |
|---|---|---|
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01/09/2022 |
Anciens postes connus de Jesper Gromada
| Sociétés | Poste | Fin |
|---|---|---|
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Laronde Inc. is a company that aims to advance eRNA-based therapeutics through their powerful new platform called endless RNA (eRNA™). The company is based in Cambridge, MA and was founded by Noubar B. Afeyan. This platform can be programmed to make any therapeutic protein inside the body, making it the most versatile RNA platform for life-changing medicines. | Corporate Officer/Principal | 01/09/2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/10/2020 |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/07/2019 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2006 |
Formation de Jesper Gromada
| University of Copenhagen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Entreprise privées | 3 |
|---|---|
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
Laronde Inc.
Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Laronde Inc. is a company that aims to advance eRNA-based therapeutics through their powerful new platform called endless RNA (eRNA™). The company is based in Cambridge, MA and was founded by Noubar B. Afeyan. This platform can be programmed to make any therapeutic protein inside the body, making it the most versatile RNA platform for life-changing medicines. | Commercial Services |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | Health Technology |
